Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I wish this was a 10% correction. It is closer to a 25% correction off the high of 8.64. do agree it is a good company, think we need some good news to get it moving again though. Otherwise, it may just continue to creep downward. GLTA
I feel like we've firmly established a new bottom to build from. A little uncomfortable, but healthy.
I hope so. No reason the little guys can't grab some cheaper shares too.
Next weeks earnings will determine a lot. I'm concerned with the new negativity and sell off. It's all based of course, on the lower guidance that the company gave for the earnings of the 19th. I holding uncomfortably right now. Maybe a flat close today to help give us a bottom.
No explanation that I know of. I think this stock is just continuing its upward move with healthy pullbacks. Nice to see us crack $8.00 today. Knew we wouldn't finish above, but great to crack the threshold. GLTA
strange that you say the same thing on a bunch of boards. Are you saying that the stock is going down 50% or is it going to skyrocket?
Wow. Another great RAD day. Just happy to be holding it. Working on $8.00 now.
got some volume back too. Great positive finish.
Alright, A day with a positive finish and not the standard surge and drop back to baseline. Hopefully, we can start here tomorrow and start heading towards 8.00
with $3,000 worth of total trading for the day, do any of the days prices really matter? IMO rebranding again, like the reverse split and dilution of the past will just continue to suck money out of investors accounts.
funny, the reason I started buying some RAD initially in the dollar range was because of speculation of buyout as well as being undervalued and poised for a turnaround with new management. Now it's grown so much in it's evaluation, that seems much less likely.
Now that's an opening. Keep going New 52 week high already.
Interesting aftermarket pop to 7.16 range. awesome to be so positive when the whole market is down.
Good to see a positive finish at the end of the day. Been here since $1.25, Love seeing whats happening with the volume since that time. The high volume after a positive breakout day really solidifies this move. Look at what a crappy two days its been for the market too. very positive here. Could see 8.00 really soon.
700 million dollars in trades today. Big institutional money is getting involved for sure.
good morning RAD. Every time you start to doubt it on the dips, something like this happens. Look at that solidifying mega volume too.
There are a lot of opinions out there. Some think it should be shorted. I've thought it was a good buy, happily since $1.50. There is still a lot of upside with the new management and potential for growth un efficiency. I sure hope your friend is right, BTW.
Looks like we head into some new territory today.
premarket is looking pretty good today.
Yeah, this has been a great ride. We are well established at this level and getting ready to make the jump to $7 and beyond.
Drug Channel Aligns Further on McKesson-Rite Aid Deal
The following is a press release from Fitch Ratings:
Fitch Ratings-New York-21 February 2014: Rite Aid Corp.'s decision this week to expand its distribution agreement with McKesson Corp. to include generic pharmaceuticals in addition to branded drugs is in line with prevailing trends in the global drug channel and in healthcare more broadly, according to Fitch Ratings. The industry trend is toward partnerships, alignment and amassing scale to cut costs in an increasingly constrained reimbursement environment.
McKesson could become the biggest beneficiary of increased generic purchasing power among global drug channel participants, Fitch believes. The drug distributor's deal with Rite Aid strengthens its position in the increasingly important area of drug purchasing scale, particularly for generics.
After overcoming a few hurdles, McKesson closed its purchase of approximately 75% of Celesio AG earlier this month. Increased scale from that deal will allow McKesson to drive cost savings, particularly related to generic drug sourcing, and future growth. The Rite Aid agreement will further enhance McKesson's drug purchasing scale and will allow Rite Aid to tap into the resulting cost savings.
Notably, unlike other drug channel participants that have largely become parties to purchasing joint ventures (JVs), McKesson will not be forced to share these cost savings with partners. Fitch estimates that McKesson's generic drug purchasing power, including Celesio and Rite Aid, will rival that of the JV among Walgreen Co., Alliance Boots GmbH and AmerisourceBergen Corp. (ABC) in the next couple of years.
The forms and progress of business combinations and alignments in the global drug channel have been diverse. But the search for cost savings from increased purchasing scales is at the core of each relationship. Joint ventures to date have included CVS Caremark Corp. and Cardinal Health as well as Walgreen's and Alliance Boots, which teamed up in 2012 and added ABC last year. Walgreens and ABC also entered into a 10-year comprehensive distribution agreement and agreed on provisions which could allow for up to 30% equity ownership of ABC by Walgreens.
These developments raise questions for other drug channel participants. CVS Caremark may need to adjust its strategy now that its two largest competitors employ a distributor for virtually all drug volumes. (CVS stores are served by Cardinal; but its Caremark business is served by McKesson.) Also, with distributors increasingly able to garner better drug pricing, the purchasing JV among Express Scripts, Kroger and Supervalu (Econdisc) comes into focus.
These developments could lead to other large pharmacy operators (i.e. Walmart, Target, Safeway) deciding to join distributors' generic programs. Walmart and Target are currently served by MCK, and Safeway by CAH. It is still too early in the business combination cycle to draw a definitive conclusion.
In Fitch's view, comprehensive distribution agreements make the most sense for retail drugstores, then for grocers/mass merchants, then for mail-order pharmacies. Still, each sector could benefit from tapping into better generic pricing derived from greater scale.
At the other end of the channel, generic drugmakers will likely feel increasing pricing pressures from these growing drug purchasers. Smaller and mid-sized generic firms will likely be most affected, possibly leading to additional consolidation over the medium term. Though the largest global generic drugmakers will be less affected, drug channel consolidation is probably contributing to the firms' focus on bolstering their presence in specialty and other branded drug development, such Actavis plc's announcement this week to acquire specialty drugmaker Forest Laboratories, Inc.
For more information on this topic, please see our "Navigating the Drug Channel" report series, available at www.fitchratings.com
wow! This Mckesson deal must be pretty significant. Great news to get up to. Time to start approaching $7! Great volume too, should help soliify the big jump.
Thanks for the link. So its Walgreens that is filing the lawsuit, not Express Scripts? Sounds like its just a mobile app that they are bickering about. So easy to make slight changes to an app and call it your own. This worries me a little less. Will watch it, but won't be pulling my money out quite yet.
Can you post a link to the lawsuit. I haven't seen any information about a lawsuit with express scripts.
great rebound the last 2 sessions. Lets see if we can march back to $6 again.
already 11 million volume and we are only 20 minutes into the day!
Good morning RAD. Nice to see 5.80 again.
thats about 7,000$in activity. Is it really significant?
Haven't we had 10:1 up days? Aren't we only 10% off our multi year high? There is over 100 million dollars in trades most days in this stock. Not like a penny stock where nay sayers have some control over the stock. Seems like a waste of time to try to create ill sentiment here. Can't we just talk facts and fundamentals?
up 15% over a couple days and 10% off the multi year high isn't sideways to me. To each their own. Volume is high again. I'll just keep buying on the dips.
another good move on high volume. Gotta love RAD
Good positive bump today. Doesn't seem to be heading to 2.00 anytime soon.
Pre market is not looking good for us after those earnings.
PE ratio, thats a bit oversimplified. What is the magic PE ratio where a stock tumbles? and what do you think about the PE ratio of tesla at 20x RAD? It was 30X RAD when it tumbled, now climbing again. This stock has went up for a year. Its had many consolidations and then repeat moves up. Most consider these buying opportunities in a growth stock. I'm watching and buying the dips.
Amazing to be anything but down on a day when the market is down so much. A very good omen IMO
I don't think that too many people are dumping here. We posters are such small potatoes compared to the 100+ million dollars in shares being exchanged each day. The momentum has been totally positive on this one with some healthy pullbacks. Definitely one of the stocks of the year.
$6.06 and climbing. Another great day for RAD. Good volume too, already pushing 20 million.
premarket remains positive. 6.00 today?
Good luck to you. no one can be faulted for taking profits. I've taken profits 3 times but continue to buy back in as this stock keeps shooting upwards.
More positive premarket action this morning. Could be heading toward that 6.00 mark. Would love to see another 30 million volume day. I certainly won't be selling anytime soon.